| Multiple machine learning, molecular docking, and ADMET screening approach for identification of selective inhibitors of CYP1B1 B Raju, H Verma, G Narendra, B Sapra, O Silakari Journal of Biomolecular Structure and Dynamics 40 (17), 7975-7990, 2022 | 18 | 2022 |
| Role of genetic polymorphisms in drug-metabolizing enzyme-mediated toxicity and pharmacokinetic resistance to anti-cancer agents: a review on the pharmacogenomics aspect G Narendra, S Choudhary, B Raju, H Verma, O Silakari Clinical Pharmacokinetics 61 (11), 1495-1517, 2022 | 15 | 2022 |
| Dihydropyrimidine Dehydrogenase-Mediated Resistance to 5-Fluorouracil: Mechanistic Investigation and Solution H Verma, G Narendra, B Raju, PK Singh, O Silakari ACS Pharmacology & Translational Science 5 (11), 1017-1033, 2022 | 13 | 2022 |
| Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review B Raju, S Choudhary, G Narendra, H Verma, O Silakari Drug Metabolism Reviews 53 (1), 45-75, 2021 | 13 | 2021 |
| Multiple machine learning models combined with virtual screening and molecular docking to identify selective human ALDH1A1 inhibitors G Narendra, B Raju, H Verma, B Sapra, O Silakari Journal of Molecular Graphics and Modelling 107, 107950, 2021 | 12 | 2021 |
| 3D‐QSAR and scaffold hopping based designing of benzo[d]ox‐azol‐2(3H)‐one and 2‐oxazolo[4,5‐b]pyridin‐2(3H)‐one derivatives as selective aldehyde … H Verma, G Narendra, B Raju, M Kumar, SK Jain, GK Tung, PK Singh, ... Archiv der Pharmazie 355 (9), 2200108, 2022 | 11 | 2022 |
| Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis G Narendra, B Raju, H Verma, O Silakari Medical Oncology 38, 1-10, 2021 | 9 | 2021 |
| QM/MM Studies on Enzyme Catalysis and Insight into Designing of New Inhibitors by ONIOM Approach: Recent Update H Sharma, B Raju, G Narendra, M Motiwale, B Sharma, H Verma, ... ChemistrySelect 8 (1), e202203319, 2023 | 6 | 2023 |
| Machine Learning Enabled Structure-Based Drug Repurposing Approach to Identify Potential CYP1B1 Inhibitors B Raju, G Narendra, H Verma, M Kumar, B Sapra, G Kaur, SK Jain, ... ACS omega 7 (36), 31999-32013, 2022 | 5 | 2022 |
| Identification of chemoresistance associated key genes-miRNAs-TFs in docetaxel resistant breast cancer by bioinformatics analysis B Raju, G Narendra, H Verma, O Silakari 3 Biotech 14 (5), 128, 2024 | 3 | 2024 |
| Classification of Potent and Weak Penetration Enhancers Using Multiple Feature Selection Methods and Machine Learning Models B Raju, N Verma, G Narendra, O Silakari, B Sapra Journal of Pharmaceutical Innovation 18 (4), 1778-1797, 2023 | 3 | 2023 |
| Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach G Narendra, B Raju, H Verma, M Kumar, SK Jain, GK Tung, S Thakur, ... International Journal of Biological Macromolecules 242, 124749, 2023 | 3 | 2023 |
| In silico guided designing of optimized benzochalcones derivatives as potent CYP1B1 inhibitors: An integrated in vitro and ONIOM study H Sharma, B Raju, G Narendra, M Kumar, H Verma, B Sharma, GK Tung, ... Journal of Molecular Graphics and Modelling 119, 108390, 2023 | 3 | 2023 |
| Identification of potential benzoxazolinones as CYP1B1 inhibitors via molecular docking, dynamics, waterswap, and in vitro analysis B Raju, H Verma, G Narendra, G Kaur, SK Jain, O Silakari New Journal of Chemistry 47 (26), 12339-12349, 2023 | 3 | 2023 |
| Scaffold hopping for designing of potent and selective CYP1B1 inhibitors to overcome docetaxel resistance: synthesis and evaluation B Raju, G Narendra, H Verma, M Kumar, B Sapra, G Kaur, SK Jain, ... Journal of Biomolecular Structure and Dynamics, 1-19, 2024 | 2 | 2024 |
| Evaluation of Cordyceps militaris steroids as antiinflammatory agents to combat the Covid-19 cytokine storm: a bioinformatics and structurebased drug designing approach Manmeet Singh, Himanshu Verma, Narendra Gera, Raju Baddipadige, Shalki ... Journal of Biomolecular Structure and Dynamics, 2023 | 2* | 2023 |
| Identification of natural peptides from “PlantPepDB” database as anti-SARS-CoV-2 agents: A protein-protein docking approach P Bhandu, H Verma, B Raju, G Narendra, S Choudhary, M Singh, ... Phytomedicine Plus 3 (2), 100446, 2023 | 2 | 2023 |
| Computational and Biological Investigations on Abl1 Tyrosine Kinase: A Review. ME Sobhia, GS Kumar, A Mallick, H Singh, K Kumar, M Chaurasiya, ... Current Drug Targets, 2020 | 2 | 2020 |
| Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation G Narendra, B Raju, H Verma, M Kumar, SK Jain, GK Tung, S Thakur, ... RSC Medicinal Chemistry 15 (1), 309-321, 2024 | 1 | 2024 |
| Network Analysis Guided Designing of Multi-Targeted Anti-Fungal Agents: Synthesis and Biological Evaluation M Singh, H Verma, P Bhandu, M Kumar, G Narendra, S Choudhary, ... Journal of molecular structure 1272, 134128, 2023 | 1 | 2023 |